MEDICINAL COMPOSITIONS CONTAINING HUMAN AMNION-ORIGIN CELLS

摘要

It is intended to provide medicinal compositions containing, as the active ingredient, epithelial cells or mesenchymal cells originating in human amnion which are usable as a substitute for human fetal stem cells because of having regeneration ability and can be relatively easily obtained by using usual surgical techniques from maternal humans giving informed consent. More specifically, medicinal compositions such as remedies for diabetes which contain the above epithelial cells as the active ingredient, or medicinal compositions such as remedies for bone metabolic errors or heart diseases which contain human amnion−origin mesenchymal cells as the active ingredient. Thus, it becomes possible to provide medicinal compositions such as remedies for diabetes by using regeneration therapy without causing any ethical problems.